BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8354486)

  • 21. Immunophenotyping of hematologic neoplasms in paraffin-embedded tissue sections.
    Davey FR; Elghetany MT; Kurec AS
    Am J Clin Pathol; 1990 Apr; 93(4 Suppl 1):S17-26. PubMed ID: 2180277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraffin section markers for Reed-Sternberg cells. A comparative study of peanut agglutinin, Leu-M1, LN-2, and Ber-H2.
    Ree HJ; Neiman RS; Martin AW; Dallenbach F; Stein H
    Cancer; 1989 May; 63(10):2030-6. PubMed ID: 2564804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunophenotypes of Reed-Sternberg cells and their variants: a study of 68 cases of Hodgkin's disease.
    Takahashi H; Hideshima K; Kawazoe K; Tsuda N; Fujita S; Shibata Y; Okabe H; Yamabe S
    Tohoku J Exp Med; 1995 Nov; 177(3):193-211. PubMed ID: 8966716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
    Frierson HF; Innes DJ
    Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K; Mori N; Kojima M
    Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of follicular dendritic reticulum cells to Reed-Sternberg cells of Hodgkin's disease with emphasis on the expression of CD21 antigen.
    Delsol G; Meggetto F; Brousset P; Cohen-Knafo E; al Saati T; Rochaix P; Gorguet B; Rubin B; Voigt JJ; Chittal S
    Am J Pathol; 1993 Jun; 142(6):1729-38. PubMed ID: 7685151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of anti-Leu-M1 (CD15) binding sites in Hodgkin's disease by immunoelectron microscopic examination.
    Taatjes DJ; Mount SL; Trainer TD; Tindle BH
    Am J Clin Pathol; 1994 Feb; 101(2):140-8. PubMed ID: 8116567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histopathological diagnosis of Hodgkin's disease].
    Delsol G
    Rev Prat; 1998 May; 48(10):1060-4. PubMed ID: 9781148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease.
    Zukerberg LR; Collins AB; Ferry JA; Harris NL
    Am J Pathol; 1991 Sep; 139(3):475-83. PubMed ID: 1716042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of Reed-Sternberg cells with granulocyte specific monoclonal antibody.
    Memon GM; Alam SM
    J Pak Med Assoc; 1993 Feb; 43(2):32-4. PubMed ID: 8497101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].
    Fu XH; Wang SS; Huang Y; Xiao J; Zhai LZ; Xia ZJ; Huang HQ; Sun XF; Lin TY
    Ai Zheng; 2008 Nov; 27(11):1197-203. PubMed ID: 19000453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Granulocyte and HLA-D region specific monoclonal antibodies in the diagnosis of Hodgkin's disease.
    Norton AJ; Isaacson PG
    J Clin Pathol; 1985 Nov; 38(11):1241-6. PubMed ID: 3864794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percentage of proliferating cell nuclear antigen (PCNA)-positive Reed-Sternberg cells in nodular sclerosis Hodgkin's disease.
    Kordek R; Biernat W; Niewiadomska H; Kupnicka D; Woźniak L; Domagała W; Osborn M
    Patol Pol; 1993; 44(3):129-31. PubMed ID: 7902558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical relevance of L26, a B-cell-specific antibody, in Hodgkin's disease.
    Molot RJ; Mendenhall NP; Barré DM; Braylan RC
    Am J Clin Oncol; 1994 Jun; 17(3):185-8. PubMed ID: 7514847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotypes of Reed-Sternberg cells: a study of 19 cases of Hodgkin's disease in plastic-embedded sections.
    Casey TT; Olson SJ; Cousar JB; Collins RD
    Blood; 1989 Dec; 74(8):2624-8. PubMed ID: 2684295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Classical Hodgkin's disease. Clinical impact of the immunophenotype.
    von Wasielewski R; Mengel M; Fischer R; Hansmann ML; Hübner K; Franklin J; Tesch H; Paulus U; Werner M; Diehl V; Georgii A
    Am J Pathol; 1997 Oct; 151(4):1123-30. PubMed ID: 9327746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies Ki-B3 and Leu-M1 discriminate giant cells of infectious mononucleosis and of Hodgkin's disease.
    Fellbaum C; Hansmann ML; Parwaresch MR; Lennert K
    Hum Pathol; 1988 Oct; 19(10):1168-73. PubMed ID: 3169725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
    Pinkus GS; Thomas P; Said JW
    Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.